Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Transplant Cell Ther. 2021 Jun 12;27(9):759.e1–759.e8. doi: 10.1016/j.jtct.2021.06.006

Figure 3. Predictive and prognostic relevance.

Figure 3.

Plasma concentrations were compared between patients with treatment success and those with treatment failure at 6 months after FAM therapy for (A) MMP-9, (B) MMP-3 and (C) YKL-40. (D) Receiver operating characteristic curves in predicting treatment failure at 6 months after FAM therapy. (E) Overall survival was compared according to MMP-9 concentrations before FAM therapy. The horizontal lines indicate means, and error bars indicate standard deviations. P values were derived from t-test. SD, standard deviation; AUC, area under the curve; CI, confidence interval.